Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil Infusion During Tracheal Extubation
NCT01152515Phase 4Completed
- Sponsor
- Severance Hospital
- Start
- May 2010
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil (2 arms), sponsored by Severance Hospital. Primary endpoints: Mean Arterial Pressure Changes During Extubation, Heart Rate Changes During Extubation and 1 more. Started May 2010; status: completed.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT01152515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01152515.